Skip to main content
. 2011 Jan;71(1):128–131. doi: 10.1111/j.1365-2125.2010.03795.x

Figure 1.

Figure 1

Change in AMP PC20 between fixed dose FP and step-down therapies. Fixed dose FP group A (Inline graphic); Step-down limb group B (Inline graphic), V1 – FP500 µg twice daily (both groups), V2 – FP250 µg twice daily vs. FP/SM 125/25 µg twice daily, V3 – FP250 µg twice daily vs. FP 125 µg twice daily, V4 – FP250 µg twice daily vs. FP/ML 125 µg twice daily/10 mg once daily. Data displayed as geometric mean and 95% CI